C14-4 (C14-494) is an ionizable lipid nanoparticle formulation designed for the efficient delivery of chimeric antigen receptor (CAR) mRNA into primary human T cells. This tool is utilized in both in vitro and in vivo research for advancing adoptive T cell therapies and immunology studies.